January 2023

Vizient, Inc. released its Winter 2023 Pharmacy Market Outlook, forecasting a 3.78% overall drug price inflation rate for the calendar year beginning, July 1, 2023.

Vizient Clinical Data Base findings revealed people with intellectual disabilities were at severe risk of contracting and dying from COVID-19. The research led to policy changes — and an ongoing mission to ensure improved healthcare experiences.

As relentless as 2022 was, Vizient’s approach to supply assurance in the face of these challenges was equally unyielding. Here’s a look at a few key lessons that have shaped (and reshaped) the way Vizient works to help its providers make the best of difficult situations — and stand firm in the face of adversity.

Biosimilars are a hot topic in pharmacy right now, but will they really have an impact on the pharmaceutical industry? Senior Principal of Pharmacy Solutions Steven Lucio answers this question and more.

A recent Vizient member survey found that active shooter protocols are seldomly used and don’t contain plans for the sickest and immobilized patients. Listen to a webinar discussing survey results, Vizient member experiences and solutions and next steps for developing industry guidelines.

In his latest blog posting entitled "College Basketball and National Health System Design” Vizient Research Institute executive director Tom Robertson describes an engaging exercise shared with audiences nationwide during 2022.

The latest news and information from Vizient regarding Research and Insights News.